EVDB: Early Versus Delayed Bathing of Orthopaedic Surgical Wounds

Sponsor
Hospital for Special Surgery, New York (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06014411
Collaborator
New York Presbyterian Hospital (Other)
56
2
16.2

Study Details

Study Description

Brief Summary

This is a single center randomized control trial assessing the effect of early versus delayed bathing on orthopaedic surgical wounds in patients undergoing surgical treatment of fractures. Patients will be recruited by screening all patients undergoing surgical treatment for fractures at our institution. Patients who provide written consent will be randomized to one of two treatment arms after confirming eligibility criteria. Group A will be advised to begin early normal bathing (non-submerged showering) with uncovered surgical wounds. Group B will be advised to follow traditional delayed bathing with covered wounds.

Condition or Disease Intervention/Treatment Phase
  • Other: Time to bathing (delayed)
  • Other: Time to bathing (early)
N/A

Detailed Description

The study is a single center, non-inferiority, parallel group, randomized control trial assessing the effect of early versus delayed bathing on orthopaedic surgical wounds in patients undergoing surgical treatment of fractures. Patients will be recruited by screening all patients undergoing surgical treatment for fractures at our institution. Patients who provide written consent will be randomized to one of two treatment arms after confirming eligibility criteria. Group A will be advised to begin early normal bathing (non-submerged showering) with uncovered surgical wounds. Group B will be advised to follow traditional delayed bathing with covered wounds.

Patients will have follow-up with data collection at two, six and 12 weeks post-operatively. The primary outcome measure will be patient satisfaction as measured by a Likert Scale. The Likert Scale as utilized will be a patient reported outcome measure consisting of one question allowing the subject to express their attitude towards a particular subject: "How satisfied are you with your surgical treatment" with possible answers consisting of: "very satisfied", "somewhat satisfied", "neutral", "somewhat unsatisfied", and "very unsatisfied". The secondary outcome measures will be development of an infection (subcategorized as either superficial or deep) and development of peri-incisional inflammation (eg. adhesive rash).

Primary Objective: The primary objective of the study is to compare patient satisfaction as measured using a Likert Scale associated with early and delayed surgical site bathing.

Secondary Objectives: The secondary objective is to compare the infection rate of orthopaedic surgical wounds between early and delayed bathing.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Early Versus Delayed Bathing of Orthopaedic Surgical Wounds: a Prospective Randomized Controlled Study
Anticipated Study Start Date :
Aug 25, 2023
Anticipated Primary Completion Date :
Aug 25, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Delayed Bathing

Delayed bathing-- patients will be told to begin showering after wound exam and suture removal (10-20 day postoperative).

Other: Time to bathing (delayed)
Delayed bathing-- patients will be told to begin showering after wound exam and suture removal (10-20 day postoperative).

Active Comparator: Early Bathing

Early bathing--Patients will be told to remove dressings and begin showering with body soap on postoperative day 3.

Other: Time to bathing (early)
Early bathing--Patients will be told to remove dressings and begin showering with body soap on postoperative day 3.

Outcome Measures

Primary Outcome Measures

  1. Patient satisfaction associated with early and delayed surgical site bathing [Weeks 2, 6 and 12 post surgery]

    The primary endpoint of the study will be a statistically significant difference in patient satisfaction as measured using a Likert Scale between the two groups.

Secondary Outcome Measures

  1. Infection rate of orthopaedic surgical wounds between early and delayed bathing [Weeks 12 post surgery]

    The secondary endpoint in this study will be a statistically significant or clinically important difference in infection rate of orthopaedic surgical wounds between the early and delayed bathing groups

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients over 18 years of age

  • Patient who are not pregnant

  • Fractures of the upper or lower extremities (humerus, radius, ulna, femur, tibia, or fibula)

  • Diagnosis of a fracture meeting indication for operative intervention

  • Any fracture not requiring a splint for post-operative management

  • Non-complicated wounds (non-traumatic wounds, closed injuries, fractures not requiring external fixation, and acute fracture surgery)

Exclusion Criteria:
  • Fractures associated with presumed infection

  • Patients with multiple fractures

  • Fractures in patients with underlying associated immune compromise

  • Fractures in patients with underlying peripheral vascular disease

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital for Special Surgery, New York
  • New York Presbyterian Hospital

Investigators

  • Principal Investigator: William M Ricci, MD, Hospital for Special Surgery, New York

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
William Ricci, Chief Orthopaedic Trauma Service, Hospital for Special Surgery, New York
ClinicalTrials.gov Identifier:
NCT06014411
Other Study ID Numbers:
  • 2023-1723
  • 21-04023565
First Posted:
Aug 28, 2023
Last Update Posted:
Aug 28, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 28, 2023